146 related articles for article (PubMed ID: 3508718)
1. Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.
Papapoulos SE; Harinck HI; Bijvoet OL; Gleed JH; Fraher LJ; O'Riordan JL
Bone Miner; 1986 Feb; 1(1):69-78. PubMed ID: 3508718
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in Paget's disease of bone.
Devlin RD; Retallack RW; Fenton AJ; Grill V; Gutteridge DH; Kent GN; Prince RL; Worth GK
J Bone Miner Res; 1994 Jan; 9(1):81-5. PubMed ID: 8154313
[TBL] [Abstract][Full Text] [Related]
4. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
[TBL] [Abstract][Full Text] [Related]
5. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
[TBL] [Abstract][Full Text] [Related]
6. The effect of recombinant PTH(1-34) and PTH(1-84) on serum ionized calcium, 1,25-dihydroxyvitamin D, and urinary calcium excretion: a pilot study.
Piemonte S; Romagnoli E; Cipriani C; Fassino V; Del Fiacco R; Carnevale V; Scillitani A; D'Erasmo E; Tancredi A; Minisola S
Calcif Tissue Int; 2009 Oct; 85(4):287-92. PubMed ID: 19756348
[TBL] [Abstract][Full Text] [Related]
7. Effect of calcium and 1,25 dihydroxyvitamin D on the level of parathyroid hormone in patients with secondary hyperparathyroidism due to chronic renal insufficiency.
Vucković S; Paunković N
Med Pregl; 1993; 46 Suppl 1():40-2. PubMed ID: 8569602
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of perioperative factors predicting hypocalcemia after thyroid and parathyroid surgery.
Chia SH; Weisman RA; Tieu D; Kelly C; Dillmann WH; Orloff LA
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):41-5. PubMed ID: 16415428
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
[TBL] [Abstract][Full Text] [Related]
12. Increases in parathyroid hormone (PTH) after gastric bypass surgery appear to be of a secondary nature.
Jin J; Robinson AV; Hallowell PT; Jasper JJ; Stellato TA; Wilhem SM
Surgery; 2007 Dec; 142(6):914-20; discussion 914-20. PubMed ID: 18063076
[TBL] [Abstract][Full Text] [Related]
13. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate.
Schweitzer DH; Oostendorp-van de Ruit M; Van der Pluijm G; Löwik CW; Papapoulos SE
J Bone Miner Res; 1995 Jun; 10(6):956-62. PubMed ID: 7572320
[TBL] [Abstract][Full Text] [Related]
15. Regulation of parathyroid hormone and vitamin D in essential hypertension.
Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
[TBL] [Abstract][Full Text] [Related]
16. Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity.
Nordenström E; Westerdahl J; Isaksson A; Lindblom P; Bergenfelz A
World J Surg; 2003 Feb; 27(2):212-5. PubMed ID: 12616439
[TBL] [Abstract][Full Text] [Related]
17. Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency.
Das G; Eligar V; Govindan J; Bondugulapati LN; Okosieme O; Davies S
Ann Clin Biochem; 2015 Jul; 52(Pt 4):462-9. PubMed ID: 25468998
[TBL] [Abstract][Full Text] [Related]
18. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
Polyzos SA; Anastasilakis AD; Makras P; Terpos E
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
[TBL] [Abstract][Full Text] [Related]
19. Regulation of calcium absorption by 1,25,dihydroxy-vitamin D--studies of the effects of a bisphosphonate treatment.
Adami S; Frijlink WB; Bijvoet OL; O'Riordan JL; Clemens TL; Papapoulos SE
Calcif Tissue Int; 1982 Jul; 34(4):317-20. PubMed ID: 6814718
[TBL] [Abstract][Full Text] [Related]
20. A survey of diagnoses in patients with a low intact parathyroid hormone concentration.
Manning EM; Fraser WD
Ann Clin Biochem; 1993 May; 30 ( Pt 3)():252-5. PubMed ID: 8517606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]